References
- Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks in cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692–5.
- Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62: 679–89.
- Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H et al. Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 1998; 339: 424–8.
- Dorum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al. Prospective detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 1999; 78: 906–11.
- Narod SA, Sun P, Gharidian P, Lynch H, Isaacs C, Garber J. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 of BRCA2 mutations: a case-control study. Lancet 2001; 357:1467–70.
- Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001; 68: 700–10.
- Whittemore AS, Harris R, Itnyre J and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184–203.
- Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B et al. Tubal ligation, hysterectomy and the risk of ovarian cancer. A prospective study. JAMA 1993; 270: 2813–18.
- Bjorge T, Engeland A, Sundfor K, Trope CG. Prognosis of 2800 patients with epithelial ovarian cancer diagnosed during 1975–94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 1998; 77: 777–81.
- Ivarsson K, Ekerydh A, Fyhr IM, Janson PO, Brannstrom M. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet Gynecol Scand 2000; 79: 777–84.
- Kreiger N, Sloan M, Cotterchio M, Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 1997; 26: 710–15.
- Ylikorkala O. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution. Acta Obstet Gynecol Scand 2000; 79: 1029–36.
- Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussel J. The risk of pregnancy after tubal sterilization: findings from the US Collaborative Review of Sterilization (CREST). Am J Obstet Gynecol 1996; 174: 1161–70.
- Wilcox LS, Chu SY, Eaker ED, Zeger SL, Peterson HB. Risk factors for regret after tubal sterilization: 5 years of follow-up in a prospective study. Fertil Steril 1991; 55: 927–33.
- Peterson HB, Jeng G, Folger SG, Hillis SA, Marchbanks PA, Wilcox LS. The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 2000; 343: 1681–7.
- Sumiala S. Later effects of female sterilization. Thesis, 2001. University of Turku, Finland.